Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
₹4.5 L
EMD Value
₹22,655
Closing Date
6 Nov 2026, 6:00 pm
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D-290/2198/Dept of Main Dispensary (Drugs)/IFA RE 226/2026-27 FOR AHRR
2026_ARMY_794590_1
2433/MS/EXP/D-290/2198/Dept of Main Dispensary (Drugs)/IFA RE 226/2026-27
Open Tender
Medical Equipments/Waste
Buy
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹22,655
Yes
17 Oct 2026
17 Oct 2026
7 Nov 2026
17 Oct 2026
6 Nov 2026
17 Oct 2026
17 Oct 2026 - 6 Nov 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Dept of Main Dispensary | |||||
| 1.01 | Losartan 50mg Tab | 23,400 | No | - | - |
| 2.01 | Tab Sevelamer 400 mg | 60,800 | No | - | - |
| 3.01 | Tab Sevelamer Carbonate 800mg | 60,400 | No | - | - |
| 4.01 | Leflunomide 10mg Tab | 8,500 | No | - | - |
| 5.01 | Leflunomide 20mg Tab | 9,400 | No | - | - |
| 6.01 | Tab Mercaptopurine 50mg | 15,000 | No | - | - |
| 7.01 | Glimepiride 2mg Tab | 1,02,000 | No | - | - |
| 8.01 | Gabapentin+Nortryptylline 100+10 | 6,300 | No | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
RFP.pdf
Tender Documents • 1.32 MB
BOQ_891163.xls
BOQ • 0.81 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .